We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$41.1B
AUM Growth
+$1.81B
Cap. Flow
+$2.06B
Cap. Flow %
5%
Top 10 Hldgs %
42.56%
Holding
315
New
30
Increased
123
Reduced
65
Closed
3

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$267M
2
DE icon
Deere & Co
DE
+$139M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$117M
4
JPM icon
JPMorgan Chase
JPM
+$114M
5
CVX icon
Chevron
CVX
+$88.5M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$90M
2
CMCSA icon
Comcast
CMCSA
+$36M
3
UNP icon
Union Pacific
UNP
+$19.2M
4
HES
Hess
HES
+$19.2M
5
KMPR icon
Kemper
KMPR
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.18%
2 Financials 18.99%
3 Healthcare 11.19%
4 Consumer Staples 11.19%
5 Energy 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
26
Abbott
ABT
$177B
$533M 1.3%
4,675,798
+486,028
+12% +$56.2M
META icon
27
Meta Platforms (Facebook)
META
$1.71T
$523M 1.27%
893,682
+119,136
+15% +$69.9M
ASML icon
28
ASML
ASML
$611B
$480M 1.17%
692,152
+46,397
+7% +$33.3M
PEP icon
29
PepsiCo
PEP
$185B
$456M 1.11%
2,985,941
-855
-0% -$140K
ADP icon
30
Automatic Data Processing
ADP
$110B
$398M 0.97%
1,358,258
+61,458
+5% +$18.2M
ABBV icon
31
AbbVie
ABBV
$465B
$392M 0.95%
2,206,188
+153,294
+7% +$28.2M
TSM icon
32
TSMC
TSM
$2.15T
$390M 0.95%
1,941,820
+115,524
+6% +$22.4M
CME icon
33
CME Group
CME
$98.9B
$354M 0.86%
1,523,436
+53,389
+4% +$12.3M
CP icon
34
Canadian Pacific Kansas City
CP
$78.3B
$351M 0.85%
4,779,943
+427,781
+10% +$33M
CB icon
35
Chubb
CB
$132B
$347M 0.84%
1,256,098
+56,679
+5% +$16.1M
BRK.B icon
36
Berkshire Hathaway Class B
BRK.B
$1.11T
$328M 0.8%
724,320
+57,822
+9% +$26.7M
NOW icon
37
ServiceNow
NOW
$147B
$325M 0.79%
1,518,130
+61,860
+4% +$12.5M
ICE icon
38
Intercontinental Exchange
ICE
$88.1B
$322M 0.78%
2,163,052
+8,484
+0.4% +$1.34M
MRK icon
39
Merck
MRK
$355B
$319M 0.77%
3,204,907
+309,716
+11% +$31.9M
MO icon
40
Altria Group
MO
$117B
$316M 0.77%
6,040,250
+352,931
+6% +$18.8M
LLY icon
41
Eli Lilly
LLY
$1.01T
$305M 0.74%
395,297
+27,422
+7% +$22.7M
MAR icon
42
Marriott International
MAR
$87.9B
$296M 0.72%
1,047,156
+25,469
+2% +$6.99M
MS icon
43
Morgan Stanley
MS
$324B
$281M 0.68%
2,238,714
+325,579
+17% +$40.1M
ADBE icon
44
Adobe
ADBE
$102B
$280M 0.68%
622,523
+49,250
+9% +$24.4M
BRK.A icon
45
Berkshire Hathaway Class A
BRK.A
$1.1T
$276M 0.67%
406
+24
+6% +$16.6M
MDLZ icon
46
Mondelez International
MDLZ
$79.3B
$270M 0.66%
4,519,695
+736,897
+19% +$48.7M
HD icon
47
Home Depot
HD
$305B
$246M 0.6%
631,481
+47,669
+8% +$19.5M
AZN icon
48
AstraZeneca
AZN
$251B
$239M 0.58%
1,821,505
+99,488
+6% +$13.9M
SHW icon
49
Sherwin-Williams
SHW
$78.5B
$237M 0.58%
697,488
-3,739
-0.5% -$1.4M
BNY
50
Bank of New York Mellon
BNY
$105B
$217M 0.53%
2,825,290
-113,920
-4% -$8.81M
1
2
3 4 5

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Fayez Sarofim & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Fayez Sarofim & Co held 315 positions worth $41.1B, up 4.6% from $39.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co deployed $2.06B of net new capital in Q4 2024, opening 30 new positions and adding to 123 existing holdings. Its largest new stake was Copart: 158,575 shares worth $9.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $90M trimmed.

  • Fayez Sarofim & Co's largest Q4 2024 buy was Copart: 158,575 shares worth $9.1M.
  • Fayez Sarofim & Co added most to NVIDIA in Q4 2024, an estimated $267M increase.
  • Fayez Sarofim & Co's biggest Q4 2024 reduction was Novo Nordisk, cutting an estimated $90M.
  • Fayez Sarofim & Co fully exited Bruker in Q4 2024, selling an estimated $227K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $41.1B portfolio in Q4 2024.
  • Fayez Sarofim & Co opened 30 new positions and closed 3 in Q4 2024.
  • Fayez Sarofim & Co's portfolio value rose 4.6% quarter-over-quarter to $41.1B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2024, filed 14 Feb 2025.